Guiding success in biotech investments.

Leading in biotech innovation: We evaluate novel molecular tools and algorithms from large-scale data to empower informed business and clinical decisions

01.

Precision Genomics and Statistical Genetics

Utilizing advanced computational techniques to evaluate and interpret complex genomic data, providing insights essential for evaluating precision medicine and diagnostic discovery opportunities.

02.

Big Data Analytics in Biostatistics, Machine Learning and Explainable AI

Applying knowledge of statistical methods and state-of-the-art machine learning algorithms to assess informatics and analytical methodologies.

03.

Multi-omics Integration

Employing genomic, proteomic and clinical metadata analyses to assess and illuminate prospective biomarkers and novel clinical tools in pathway and interaction networks.

Key Expertise

Specializing in the evaluation of groundbreaking molecular diagnostic tools.

We are strategically positioned to expertly guide biotechnology companies and investment firms through the ever-evolving landscape of biotech investments. Our impressive track record involves harnessing large scale molecular data to craft cutting-edge algorithms, resulting in robust biomarkers and tools that empower physicians in making informed clinical decisions. Backed by a network that includes seasoned physicians,experienced patent attorneys, and other successful veterans of the biotechnology sector, HelixHarbor offers a distinctive synergy of technical excellence and unparalleled industry insight. Join us in shaping the future of biotech investment with cutting-edge innovation.

Assessing novel clinical tools that employ:

• biomarkers

• gene expression

• immunotherapy

• genotyping

• sequencing methodologies
  

• whole genome

• whole exome

• targeted sequencing

• single-cell sequencing

We are here to help

Talk to our informatics team today. We tailor our services around your analytical needs so that we can meet your goals as fast as possible.